Nuclein secures $14m funding to commercialise hand-held PCR device
US-based medical device company Nuclein has secured $14m in a Series B funding round to commercialise its hand-held PCR platform. The financing round was led by Trinity Private
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XUS-based medical device company Nuclein has secured $14m in a Series B funding round to commercialise its hand-held PCR platform. The financing round was led by Trinity Private
Thermo Fisher Scientific today announced the completion of the U.S. Food and Drug Administration (FDA) listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System. The innovative
The University of Georgia researcher Jagadish Mahendran, along with his team, has developed an artificial intelligence (AI)-powered, voice-activated backpack to help the visually impaired navigate. The backpack is
Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, today announced approval from the Japanese Ministry of
Ava has unveiled its plans to commence the first clinical study to evaluate the effectiveness of its Fertility Tracking Bracelet in detecting Covid-19 infection in real-time. The new
Thermo Fisher Scientific, the world leader in serving science, and Artificial, developers of flexible automation software, have announced a strategic technology collaboration to develop an integrated and comprehensive software
Health2047, a Silicon Valley-based subsidiary of the American Medical Association (AMA), has announced the spin out of its phenotype testing company Phenomix Sciences. Phenomix offers a diagnostic solution
Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated
US-based medical device company Insulet has unveiled positive outcomes for its Omnipod 5 Automated Insulin Delivery System in a clinical study. The automated insulin delivery system has been
BIOCORP (FR0012788065 – ALCOR / Eligible PEA PME) (Paris:ALCOR), a French company specialized in the development and manufacturing of medical devices and connected solutions in the health sector